Ivana Hálová

612 total citations
21 papers, 509 citations indexed

About

Ivana Hálová is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ivana Hálová has authored 21 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ivana Hálová's work include Mast cells and histamine (17 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cell Adhesion Molecules Research (6 papers). Ivana Hálová is often cited by papers focused on Mast cells and histamine (17 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cell Adhesion Molecules Research (6 papers). Ivana Hálová collaborates with scholars based in Czechia, United States and Russia. Ivana Hálová's co-authors include Petr Dráber, Lubica Dráberová, Iva Polakovičová, Toshiaki Kawakami, Monika Bambousková, Viktor Bugajev, Harissios Vliagoftis, Elin Rönnberg, Gunnar Nilsson and Francesca Levi‐Schaffer and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ivana Hálová

21 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivana Hálová Czechia 13 367 168 147 109 53 21 509
Yves T. Falanga United States 11 315 0.9× 247 1.5× 90 0.6× 166 1.5× 20 0.4× 15 570
Kai-Ting Shade United States 7 301 0.8× 224 1.3× 126 0.9× 130 1.2× 147 2.8× 7 575
M. Yanagida Japan 8 524 1.4× 161 1.0× 210 1.4× 218 2.0× 37 0.7× 12 619
Grant R. Stenton Canada 14 289 0.8× 166 1.0× 114 0.8× 171 1.6× 61 1.2× 23 615
Ryoichi Hashida Japan 11 147 0.4× 126 0.8× 86 0.6× 94 0.9× 29 0.5× 24 406
Alan Xu China 10 237 0.6× 135 0.8× 48 0.3× 66 0.6× 26 0.5× 12 458
Jun-ichi Kashiwakura Japan 8 358 1.0× 104 0.6× 154 1.0× 165 1.5× 13 0.2× 8 549
K. Merétey Hungary 9 235 0.6× 121 0.7× 47 0.3× 74 0.7× 57 1.1× 19 450
Shunsuke Kanada Japan 11 284 0.8× 88 0.5× 75 0.5× 70 0.6× 15 0.3× 16 397
JC Anthes United States 3 355 1.0× 161 1.0× 85 0.6× 102 0.9× 15 0.3× 3 447

Countries citing papers authored by Ivana Hálová

Since Specialization
Citations

This map shows the geographic impact of Ivana Hálová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivana Hálová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivana Hálová more than expected).

Fields of papers citing papers by Ivana Hálová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivana Hálová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivana Hálová. The network helps show where Ivana Hálová may publish in the future.

Co-authorship network of co-authors of Ivana Hálová

This figure shows the co-authorship network connecting the top 25 collaborators of Ivana Hálová. A scholar is included among the top collaborators of Ivana Hálová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivana Hálová. Ivana Hálová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bugajev, Viktor, et al.. (2023). Simultaneous reduction of all ORMDL proteins decreases the threshold of mast cell activation. Scientific Reports. 13(1). 9615–9615. 5 indexed citations
2.
Bugajev, Viktor, Ivana Hálová, Ladislav Kuchař, et al.. (2021). Crosstalk between ORMDL3, serine palmitoyltransferase, and 5-lipoxygenase in the sphingolipid and eicosanoid metabolic pathways. Journal of Lipid Research. 62. 100121–100121. 7 indexed citations
3.
Bugajev, Viktor, Ivana Hálová, Lubica Dráberová, et al.. (2021). ORMDL2 Deficiency Potentiates the ORMDL3-Dependent Changes in Mast Cell Signaling. Frontiers in Immunology. 11. 591975–591975. 10 indexed citations
4.
Dráberová, Lubica, Helena Draberova, Ivana Hálová, et al.. (2020). Cytoskeletal Protein 4.1R Is a Positive Regulator of the FcεRI Signaling and Chemotaxis in Mast Cells. Frontiers in Immunology. 10. 3068–3068. 10 indexed citations
5.
Orinska, Zane, et al.. (2020). Tetraspanins in the regulation of mast cell function. Medical Microbiology and Immunology. 209(4). 531–543. 12 indexed citations
6.
Dráber, Petr, Ivana Hálová, Ladislav Kuchař, et al.. (2020). Production of leukotriene signaling mediators is limited by ORMDL3/serine palmitoyltransferase/5-lipoxygenase crosstalk. The Journal of Immunology. 204(1_Supplement). 152.18–152.18. 1 indexed citations
7.
Hálová, Ivana, Elin Rönnberg, Lubica Dráberová, et al.. (2018). Changing the threshold—Signals and mechanisms of mast cell priming. Immunological Reviews. 282(1). 73–86. 43 indexed citations
8.
9.
Hálová, Ivana, Monika Bambousková, Lubica Dráberová, Viktor Bugajev, & Petr Dráber. (2018). The transmembrane adaptor protein NTAL limits mast cell chemotaxis toward prostaglandin E 2. Science Signaling. 11(556). 4 indexed citations
10.
Hálová, Ivana & Petr Dráber. (2016). Tetraspanins and Transmembrane Adaptor Proteins As Plasma Membrane Organizers—Mast Cell Case. Frontiers in Cell and Developmental Biology. 4. 43–43. 24 indexed citations
11.
Bambousková, Monika, Iva Polakovičová, Ivana Hálová, et al.. (2016). New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling. Molecular and Cellular Biology. 36(9). 1366–1382. 25 indexed citations
12.
Dráber, Petr, Ivana Hálová, Iva Polakovičová, & Toshiaki Kawakami. (2015). Signal transduction and chemotaxis in mast cells. European Journal of Pharmacology. 778. 11–23. 62 indexed citations
13.
Bugajev, Viktor, Ivana Hálová, Lubica Dráberová, et al.. (2015). Negative regulatory roles of ORMDL3 in the FcεRI-triggered expression of proinflammatory mediators and chemotactic response in murine mast cells. Cellular and Molecular Life Sciences. 73(6). 1265–1285. 26 indexed citations
14.
15.
Hálová, Ivana, Lubica Dráberová, Monika Bambousková, et al.. (2013). Cross-talk between Tetraspanin CD9 and Transmembrane Adaptor Protein Non-T Cell Activation Linker (NTAL) in Mast Cell Activation and Chemotaxis. Journal of Biological Chemistry. 288(14). 9801–9814. 21 indexed citations
16.
Hálová, Ivana, Lubica Dráberová, & Petr Dráber. (2012). Mast Cell Chemotaxis – Chemoattractants and Signaling Pathways. Frontiers in Immunology. 3. 119–119. 140 indexed citations
17.
Dráber, Petr, Ivana Hálová, Francesca Levi‐Schaffer, & Lubica Dráberová. (2012). Transmembrane Adaptor Proteins in the High-Affinity IgE Receptor Signaling. Frontiers in Immunology. 2. 95–95. 28 indexed citations
18.
Dráberová, Lubica, et al.. (2004). Signaling assemblies formed in mast cells activated via Fcϵ receptor I dimers. European Journal of Immunology. 34(8). 2209–2219. 22 indexed citations
19.
Hálová, Ivana, Lubica Dráberová, & Petr Dráber. (2002). A novel lipid raft-associated glycoprotein, TEC-21, activates rat basophilic leukemia cells independently of the type 1 Fcε receptor. International Immunology. 14(2). 213–223. 15 indexed citations
20.
Dráber, Petr, Lubica Dráberová, Martina Kovářová, et al.. (2001). Lipid Rafts and Their Role in Signal Transduction-Mast Cells as a Model. Trends in Glycoscience and Glycotechnology. 13(71). 261–279. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yves T. Falanga Breakdown of academic impact, for papers by Kai-Ting Shade Breakdown of academic impact, for papers by M. Yanagida Breakdown of academic impact, for papers by Grant R. Stenton Breakdown of academic impact, for papers by Ryoichi Hashida Breakdown of academic impact, for papers by Alan Xu Breakdown of academic impact, for papers by Jun-ichi Kashiwakura Breakdown of academic impact, for papers by K. Merétey Breakdown of academic impact, for papers by Shunsuke Kanada Breakdown of academic impact, for papers by JC Anthes
Rankless by CCL
2026